MSB 3.21% $1.13 mesoblast limited

here's a thought

  1. 1,365 Posts.
    lightbulb Created with Sketch. 116
    my view is this. the fact that the DMC has confirmed continuation of the trial, can only mean that results are positive. Why because if they weren't patient would be required to revert back to conventional therapies, we are talking about life and death here. and I would assume improvements would need to be substantial, minimal deviation would not cut it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.